These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 648235)

  • 21. [Information on a visit to India (5-17--6-18 1969)].
    Kolesov KA; Loginov VK
    Vestn Dermatol Venerol; 1970 Aug; 44(8):88-91. PubMed ID: 5494202
    [No Abstract]   [Full Text] [Related]  

  • 22. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy latensification. I. Saccharide polymers of biologically active amines].
    Korolkovas A; Igne Ferreira E
    Rev Farm Bioquim Univ Sao Paulo; 1972; 10(1):97-112. PubMed ID: 4645500
    [No Abstract]   [Full Text] [Related]  

  • 24. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
    Stewart LB; Peters W; Robinson BL
    Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of "P. falciparum" malaria by delayed-action sulfonamides].
    Verdrager J; Riche A; Chheang CM
    Presse Med (1893); 1967 Dec; 75(55):2839-40. PubMed ID: 4868771
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimalarial studies on 4,4-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals.
    Thompson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):605-15. PubMed ID: 5626306
    [No Abstract]   [Full Text] [Related]  

  • 27. A short history of dapsone, or an alternative model of drug development.
    Barr J
    Pharm Hist; 2011; 53(4):123-47. PubMed ID: 24620474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
    Simpson JA; Hughes D; Manyando C; Bojang K; Aarons L; Winstanley P; Edwards G; Watkins WA; Ward S
    Br J Clin Pharmacol; 2006 Mar; 61(3):289-300. PubMed ID: 16487222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man.
    Clyde DF; Rebert CC; McCarthy VC; Dawkins AT; Cucinell SA
    Mil Med; 1970 Jul; 135(7):527-36. PubMed ID: 4991753
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium.
    Urbán P; Valle-Delgado JJ; Mauro N; Marques J; Manfredi A; Rottmann M; Ranucci E; Ferruti P; Fernàndez-Busquets X
    J Control Release; 2014 Mar; 177():84-95. PubMed ID: 24412735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents.
    Bekhit AA; Hassan AM; Abd El Razik HA; El-Miligy MM; El-Agroudy EJ; Bekhit Ael-D
    Eur J Med Chem; 2015 Apr; 94():30-44. PubMed ID: 25768697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology and prevention of Leucocytozoon smithi infection of Turkeys.
    Siccardi FJ; Rutherford HO; Derieux WT
    Avian Dis; 1974; 18(1):21-32. PubMed ID: 4205345
    [No Abstract]   [Full Text] [Related]  

  • 36. The search for new antimalarial drugs.
    Strube RE
    J Trop Med Hyg; 1975 Aug; 78(8):171-85. PubMed ID: 813015
    [No Abstract]   [Full Text] [Related]  

  • 37. Malaria incidence in leprosy patients under dapsone therapy in Karbi-Anglong district, Assam.
    Das S; Barkakaty BN; Talukdar A; Roy RG; Pattanayak S
    J Commun Dis; 1982 Jun; 14(2):134-7. PubMed ID: 6759567
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiparasitic agents. Part 7--Antimalarial activity of alkyl 5(6)-(4-aminophenyl) sulphonobenzimidazole-2-carbamates.
    Chandra S; Das PK; Dutta GP; Dutta GD; Abuzar S; Sharma S
    Indian J Malariol; 1987 Jun; 24(1):17-9. PubMed ID: 3326751
    [No Abstract]   [Full Text] [Related]  

  • 39. Sequential blockade of the mycobacterial de novo folate pathway. A review.
    Morrison NE
    Int J Lepr Other Mycobact Dis; 1971; 39(1):34-43. PubMed ID: 4399473
    [No Abstract]   [Full Text] [Related]  

  • 40. Thiosemicarbazones and hydrazones of alpha-methylchalkone as potential chemotherapeutic agents.
    Prescott B
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):332-5. PubMed ID: 1099024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.